Brad KnottSell
ORMP · Transaction Jan 10, 2025 · Filed Feb 25, 2025 · $15,001 to $50,000
NASDAQ NMS - GLOBAL MARKET · ORMP
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Oramed Pharmaceuticals Inc
Pharmaceuticals
$4.57
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET · ORMP
MethodologyORMP
Oramed Pharmaceuticals Inc
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
57/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ORMP moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Oramed Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONSListed since
2004
Employees
13
Country
US
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$4.57
Last session
Day high
$4.57
Last session
Day low
$4.57
Last session
Previous close
$4.57
52W high
$5.00
-8.60% from high
52W low
$2.06
85% of range
Market cap
$186.4M
P/E
1.48×
EPS
$3.09
Beta
0.94
Shares out
41.6M
Avg volume
177.3K
VWAP
$4.57
Last session
Price history computed in-house
1W
+7.53%
1M
+13.40%
3M
+6.78%
1Y
+119.71%
YTD
+60.35%
SMA 50 $4.17 · above
SMA 200 $3.55 · above
52W position 85%
ORMP overview
Related filings and maps
Public disclosures
Congress activity in ORMP
Official filing ↗
Disclosed security · Transaction Jan 14, 2022 · Filed Jan 14, 2022 · $1,001 to $15,000
Andrew GarbarinoSell
ORMP · Transaction Oct 1, 2021 · Filed Nov 3, 2021 · $1,001 to $15,000
ORMP · Transaction Apr 23, 2021 · Filed May 24, 2021 · $1,001 to $15,000
Federal contracts
ORMP contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ORMP in this window.
Lobbying spend
ORMP lobbying filings, year to date.
Registered lobbying filings matched to Oramed Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ORMP in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ORMP.
Options
Sovereign unlock shows live options positioning for ORMP.